Inflammatory Bowel Diseases

Cover image for Vol. 17 Issue 1

January 2011

Volume 17, Issue 1

Pages 1–490

  1. Editorials

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
  2. Original Clinical Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
  3. Editorials

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Assessing disease risk in pediatric ulcerative colitis (pages 13–14)

      Joel R. Rosh

      Version of Record online: 13 JUL 2010 | DOI: 10.1002/ibd.21392

  4. Original Clinical Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Clinical variables as prognostic tools in pediatric-onset ulcerative colitis: A retrospective cohort study (pages 15–21)

      Jill C. Moore, Kimberly Thompson, Bonnie LaFleur, Linda S. Book, W. Daniel Jackson, Molly A. O'Gorman, Richard E. Black, Earl Downey Jr, Dale G. Johnson, Michael E. Matlak, Rebecka L. Meyers, Eric Scaife and Stephen L. Guthery

      Version of Record online: 13 JUL 2010 | DOI: 10.1002/ibd.21393

    2. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis (pages 22–29)

      Sheree Watson, Licia Pensabene, Paul Mitchell and Athos Bousvaros

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21418

    3. Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease (pages 30–38)

      Corey A. Siegel, Lori S. Siegel, Jeffrey S. Hyams, Subra Kugathasan, James Markowitz, Joel R. Rosh, Neal Leleiko, David R. Mack, Wallace Crandall, Jonathan Evans, David J. Keljo, Anthony R. Otley, Maria Oliva-Hemker, Sharmayne Farrior, Christine R. Langton, Iwona T. Wrobel, Ghassan Wahbeh, J. Antonio Quiros, Gary Silber, Ron J. Bahar, Bruce E. Sands and Marla C. Dubinsky

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/ibd.21386

    4. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease (pages 39–44)

      Amnon Sonnenberg, Shelby D. Melton and Robert M. Genta

      Version of Record online: 19 MAY 2010 | DOI: 10.1002/ibd.21356

    5. Lymphocytic esophagitis: A possible manifestation of pediatric upper gastrointestinal Crohn's disease (pages 45–49)

      Dawn R. Ebach, Andrew D. Vanderheyden, Jason M. Ellison and Chris S. Jensen

      Version of Record online: 19 MAY 2010 | DOI: 10.1002/ibd.21347

    6. Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease (pages 50–55)

      Judith R. Kelsen, Jason Kim, Dan Latta, Sarah Smathers, Karin L. McGowan, Theodore Zaoutis, Petar Mamula and Robert N. Baldassano

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21421

    7. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series (pages 56–61)

      Jennifer L. Dotson, Wallace Crandall, Hayat Mousa, Jonathan R. Honegger, Lee Denson, Charles Samson, Dennis Cunningham, Jane Balint, Molly Dienhart, Preeti Jaggi and Ryan Carvalho

      Version of Record online: 19 JUL 2010 | DOI: 10.1002/ibd.21378

    8. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease (pages 62–68)

      Michael D. Kappelman, Carol Q. Porter, Joseph A. Galanko, Sheryl L. Rifas-Shiman, Daniel A. Ollendorf, Robert S. Sandler and Jonathan A. Finkelstein

      Version of Record online: 17 JUN 2010 | DOI: 10.1002/ibd.21371

    9. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study (pages 69–76)

      Pauline Roumeguère, Dominique Bouchard, François Pigot, Alain Castinel, Frederic Juguet, Delphine Gaye, Maylis Capdepont, Frank Zerbib and David Laharie

      Version of Record online: 8 JUL 2010 | DOI: 10.1002/ibd.21405

    10. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States (pages 77–83)

      Bashar J. Qumseya, Ashwin N. Ananthakrishnan, Sue Skaros, Michael Bonner, Mazen Issa, Yelena Zadvornova, Amar Naik, Lilani Perera and David G. Binion

      Version of Record online: 10 MAY 2010 | DOI: 10.1002/ibd.21329

    11. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases (pages 84–90)

      Pavol Papay, Alexander Eser, Stefan Winkler, Sophie Frantal, Christian Primas, Wolfgang Miehsler, Gottfried Novacek, Harald Vogelsang, Clemens Dejaco and Walter Reinisch

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21427

    12. Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease (pages 91–98)

      Florian Beigel, Fabian Schnitzler, Rüdiger Paul Laubender, Simone Pfennig, Maria Weidinger, Burkhard Göke, Julia Seiderer, Thomas Ochsenkühn and Stephan Brand

      Version of Record online: 17 JUN 2010 | DOI: 10.1002/ibd.21362

    13. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent (pages 99–104)

      Sreedhar Subramanian, Vijay Yajnik, Bruce E. Sands, Garret Cullen and Joshua R. Korzenik

      Version of Record online: 13 JUL 2010 | DOI: 10.1002/ibd.21370

    14. Short CDAI: Development and validation of a shortened and simplified Crohn's disease activity index (pages 105–111)

      Kelvin Thia, William A. Faubion Jr, Edward V. Loftus Jr, Tore Persson, Anders Persson and William J. Sandborn

      Version of Record online: 13 JUL 2010 | DOI: 10.1002/ibd.21400

    15. Short pediatric Crohn's disease activity index for quality improvement and observational research (pages 112–117)

      Michael D. Kappelman, Wallace V. Crandall, Richard B. Colletti, Anthony Goudie, Ian H. Leibowitz, Lynn Duffy, David E. Milov, Sandra C. Kim, Bess T. Schoen, Ashish S. Patel, John Grunow, Evette Larry, Gerry Fairbrother and Peter Margolis

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/ibd.21452

    16. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection (pages 118–126)

      Miguel Regueiro, Kevin E. Kip, Wolfgang Schraut, Leonard Baidoo, Antonia R. Sepulveda, Marilyn Pesci, Sandra El-Hachem, Janet Harrison and David Binion

      Version of Record online: 27 MAY 2010 | DOI: 10.1002/ibd.21355

    17. Risk–benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease (pages 127–140)

      Edward V. Loftus Jr, Scott J. Johnson, Si-Tien Wang, Eric Wu, Parvez M. Mulani and Jingdong Chao

      Version of Record online: 1 JUN 2010 | DOI: 10.1002/ibd.21341

    18. Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics (pages 141–151)

      William J. Sandborn, Jean-Frédéric Colombel, Stefan Schreiber, Scott E. Plevy, Paul F. Pollack, Anne M. Robinson, Jingdong Chao and Parvez Mulani

      Version of Record online: 10 MAY 2010 | DOI: 10.1002/ibd.21328

    19. Adherence to adalimumab therapy in Crohn's disease: A French multicenter experience (pages 152–159)

      Vincent Billioud, David Laharie, Jérôme Filippi, Xavier Roblin, Abderrahim Oussalah, Jean-Baptiste Chevaux, Xavier Hébuterne, Marc-André Bigard and Laurent Peyrin-Biroulet

      Version of Record online: 8 NOV 2010 | DOI: 10.1002/ibd.21491

    20. Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases (pages 160–170)

      Gilles Boschetti, Stéphane Nancey, Fatima Sardi, Xavier Roblin, Bernard Flourié and Dominique Kaiserlian

      Version of Record online: 6 MAY 2010 | DOI: 10.1002/ibd.21308

  5. Original Basic Science Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens (pages 171–178)

      Rivkah Gonsky, Richard L. Deem, Carol J. Landers, Carrie A. Derkowski, Dror Berel, Dermot P.B. McGovern and Stephan R. Targan

      Version of Record online: 19 MAY 2010 | DOI: 10.1002/ibd.21352

    2. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases (pages 179–184)

      Daniel N. Frank, Charles E. Robertson, Christina M. Hamm, Zegbeh Kpadeh, Tianyi Zhang, Hongyan Chen, Wei Zhu, R. Balfour Sartor, Edgar C. Boedeker, Noam Harpaz, Norman R. Pace and Ellen Li

      Version of Record online: 13 SEP 2010 | DOI: 10.1002/ibd.21339

    3. Highlighting new phylogenetic specificities of Crohn's disease microbiota (pages 185–192)

      S. Mondot, S. Kang, J.P. Furet, D. Aguirre de Carcer, C. McSweeney, M. Morrison, P. Marteau, J. Doré and M. Leclerc

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21436

    4. Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures (pages 193–201)

      Robert S. Flynn, Sunila Mahavadi, Karnam S. Murthy, John R. Grider, John M. Kellum, Homayoon Akbari and John F. Kuemmerle

      Version of Record online: 19 MAY 2010 | DOI: 10.1002/ibd.21351

    5. Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and strictures (pages 202–212)

      Johannes K.-H. Meier, Michael Scharl, Sandra N. Miller, Julia Brenmoehl, Martin Hausmann, Silvia Kellermeier, Jürgen Schölmerich and Gerhard Rogler

      Version of Record online: 10 MAY 2010 | DOI: 10.1002/ibd.21344

    6. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation (pages 221–231)

      Alexandru V. Olaru, Florin M. Selaru, Yuriko Mori, Christine Vazquez, Stefan David, Bogdan Paun, Yulan Cheng, Zhe Jin, Jian Yang, Rachana Agarwal, John M. Abraham, Themistocles Dassopoulos, Mary Harris, Theodore M. Bayless, John Kwon, Noam Harpaz, Ferenc Livak and Stephen J. Meltzer

      Version of Record online: 1 JUN 2010 | DOI: 10.1002/ibd.21359

    7. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer (pages 232–240)

      Camille Laurent, Magali Svrcek, Jean-François Flejou, Marie-Pierre Chenard, Bernard Duclos, Jean-Noël Freund and Jean-Marie Reimund

      Version of Record online: 2 SEP 2010 | DOI: 10.1002/ibd.21451

    8. Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohn's disease (pages 241–250)

      Feng Wu, Natalie Jia Guo, Hongying Tian, Michael Marohn, Susan Gearhart, Theodore M. Bayless, Steven R. Brant and John H. Kwon

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/ibd.21450

    9. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease (pages 251–259)

      Shradha Agarwal, Paul Smereka, Noam Harpaz, Charlotte Cunningham-Rundles and Lloyd Mayer

      Version of Record online: 13 JUL 2010 | DOI: 10.1002/ibd.21376

    10. Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells (pages 260–267)

      Manjula Puthenedam, Feng Wu, Alysha Shetye, Alex Michaels, Ki-Jong Rhee and John H. Kwon

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/ibd.21443

    11. Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis (pages 268–278)

      Koichi Takebayashi, Iurii Koboziev, Dmitry V. Ostanin, Laura Gray, Fridrik Karlsson, Sherry A. Robinson-Jackson, Melissa Kosloski-Davidson, Angela Burrows Dooley, Songlin Zhang and Matthew B. Grisham

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/ibd.21447

    12. Blockade of LTB4/BLT1 pathway improves CD8+ T-cell-mediated colitis (pages 279–288)

      Stephane Nancey, Gilles Boschetti, Feriel Hacini, Fatima Sardi, Pierre-Yves Durand, Maylis Le Borgne, Lydie Furhmann, Bernard Flourie and Dominique Kaiserlian

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21404

    13. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis (pages 289–297)

      Joshua M. Uronis, Janelle C. Arthur, Temitope Keku, Anthony Fodor, Ian M. Carroll, Myrella L. Cruz, Caroline B. Appleyard and Christian Jobin

      Version of Record online: 17 JUN 2010 | DOI: 10.1002/ibd.21366

    14. Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease (pages 298–307)

      Marie McDonnell, YanMei Liang, Ansu Noronha, Jennifer Coukos, Dennis L. Kasper, Francis A. Farraye and Lisa M. Ganley-Leal

      Version of Record online: 30 AUG 2010 | DOI: 10.1002/ibd.21424

    15. Enteroantigen-presenting B cells efficiently stimulate CD4+ T cells in vitro (pages 308–318)

      Esben Gjerløff Wedebye Schmidt, Nanna Ny Kristensen, Mogens Helweg Claesson and Anders Elm Pedersen

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21429

    16. The Stress signal extracellular ATP modulates antiflagellin immune responses in intestinal epithelial cells (pages 319–333)

      Sabine M. Ivison, Megan E. Himmel, Matt Mayer, Yu Yao, Arnawaz Kifayet, Megan K. Levings and Theodore S. Steiner

      Version of Record online: 18 AUG 2010 | DOI: 10.1002/ibd.21428

  6. Editorials

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Introduction to Cochrane systematic reviews (pages 334–335)

      Brian G. Feagan, John W. McDonald, Nilesh Chande and John K. MacDonald

      Version of Record online: 2 JUN 2010 | DOI: 10.1002/ibd.21372

  7. Cochrane Systematic Reviews

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): A systematic review and meta-analyses (pages 336–345)

      Dan Turner, Prakesh S. Shah, A. Hillary Steinhart, Stanley Zlotkin and Anne M. Griffiths

      Version of Record online: 17 JUN 2010 | DOI: 10.1002/ibd.21374

  8. Basic Review Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Genetics of childhood-onset inflammatory bowel disease (pages 346–361)

      Paul Henderson, Johan E. van Limbergen, David C. Wilson, Jack Satsangi and Richard K. Russell

      Version of Record online: 19 APR 2010 | DOI: 10.1002/ibd.21283

    2. Importance of disrupted intestinal barrier in inflammatory bowel diseases (pages 362–381)

      Sa'ad Y. Salim and Johan D. Söderholm

      Version of Record online: 19 AUG 2010 | DOI: 10.1002/ibd.21403

    3. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease (pages 382–395)

      Paul Henderson, Johan E. van Limbergen, Jürgen Schwarze and David C. Wilson

      Version of Record online: 19 JUL 2010 | DOI: 10.1002/ibd.21379

    4. The struggle within: Microbial influences on colorectal cancer (pages 396–409)

      Janelle C. Arthur and Christian Jobin

      Version of Record online: 27 MAY 2010 | DOI: 10.1002/ibd.21354

  9. Pediatric Review Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends (pages 423–439)

      Eric I. Benchimol, Kyle J. Fortinsky, Peter Gozdyra, Meta Van den Heuvel, Johan Van Limbergen and Anne M. Griffiths

      Version of Record online: 27 MAY 2010 | DOI: 10.1002/ibd.21349

    2. Acute severe ulcerative colitis in children: A systematic review (pages 440–449)

      Dan Turner and Anne M. Griffiths

      Version of Record online: 19 JUL 2010 | DOI: 10.1002/ibd.21383

    3. ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network (pages 450–457)

      Wallace Crandall, Michael D. Kappelman, Richard B. Colletti, Ian Leibowitz, John E. Grunow, Sabina Ali, Howard I. Baron, James H. Berman, Brendan Boyle, Stanley Cohen, Fernando del Rosario, Lee A. Denson, Lynn Duffy, Mark J. Integlia, Sandra C. Kim, David Milov, Ashish S. Patel, Bess T. Schoen, Dorota Walkiewicz and Peter Margolis

      Version of Record online: 2 JUL 2010 | DOI: 10.1002/ibd.21394

  10. Clinical Review Articles

    1. Top of page
    2. Editorials
    3. Original Clinical Articles
    4. Editorials
    5. Original Clinical Articles
    6. Original Basic Science Articles
    7. Editorials
    8. Cochrane Systematic Reviews
    9. Basic Review Articles
    10. Pediatric Review Articles
    11. Clinical Review Articles
    1. Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention (pages 458–470)

      Naamah L. Zitomersky, Menno Verhave and Cameron C. Trenor III

      Version of Record online: 27 MAY 2010 | DOI: 10.1002/ibd.21334

    2. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts (pages 471–478)

      Laurent Peyrin-Biroulet, Edward V. Loftus Jr, Jean-Frederic Colombel and William J. Sandborn

      Version of Record online: 19 AUG 2010 | DOI: 10.1002/ibd.21417

    3. Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease (pages 479–484)

      Carla S. Coffin, Hughie F. Fraser, Remo Panaccione and Subrata Ghosh

      Version of Record online: 19 MAY 2010 | DOI: 10.1002/ibd.21336

SEARCH

SEARCH BY CITATION